374 related articles for article (PubMed ID: 25826649)
21. The association between estradiol levels, hormonal contraceptive use, and responsiveness to one-session-treatment for spider phobia in women.
Graham BM; Li SH; Black MJ; Öst LG
Psychoneuroendocrinology; 2018 Apr; 90():134-140. PubMed ID: 29482136
[TBL] [Abstract][Full Text] [Related]
22. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
Hofmann SG; Carpenter JK; Otto MW; Rosenfield D; Smits JA; Pollack MH
Contemp Clin Trials; 2015 Jul; 43():223-30. PubMed ID: 26111923
[TBL] [Abstract][Full Text] [Related]
23. Generalization of Extinguished Fear to Untreated Fear Stimuli after Exposure.
Preusser F; Margraf J; Zlomuzica A
Neuropsychopharmacology; 2017 Dec; 42(13):2545-2552. PubMed ID: 28589965
[TBL] [Abstract][Full Text] [Related]
24. Contamination-Focused Exposure as a Treatment for Disgust-Based Fears: A Preliminary Test in Spider-Fearful Women.
Cougle JR; Summers BJ; Harvey AM; Dillon KH; Allan NP
Behav Cogn Psychother; 2016 Nov; 44(6):640-651. PubMed ID: 27465309
[TBL] [Abstract][Full Text] [Related]
25. Long-term oxytocin administration enhances the experience of attachment.
Bernaerts S; Prinsen J; Berra E; Bosmans G; Steyaert J; Alaerts K
Psychoneuroendocrinology; 2017 Apr; 78():1-9. PubMed ID: 28131072
[TBL] [Abstract][Full Text] [Related]
26. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial.
Meyerbroeker K; Powers MB; van Stegeren A; Emmelkamp PM
Psychother Psychosom; 2012; 81(1):29-37. PubMed ID: 22116378
[TBL] [Abstract][Full Text] [Related]
27. Positive valence reduces susceptibility to return of fear and enhances approach behavior.
Dour HJ; Brown LA; Craske MG
J Behav Ther Exp Psychiatry; 2016 Mar; 50():277-82. PubMed ID: 26497447
[TBL] [Abstract][Full Text] [Related]
28. Intranasal Oxytocin Normalizes Amygdala Functional Connectivity in Posttraumatic Stress Disorder.
Koch SB; van Zuiden M; Nawijn L; Frijling JL; Veltman DJ; Olff M
Neuropsychopharmacology; 2016 Jul; 41(8):2041-51. PubMed ID: 26741286
[TBL] [Abstract][Full Text] [Related]
29. The association between fear extinction, the ability to accomplish exposure and exposure therapy outcome in specific phobia.
Raeder F; Merz CJ; Margraf J; Zlomuzica A
Sci Rep; 2020 Mar; 10(1):4288. PubMed ID: 32152429
[TBL] [Abstract][Full Text] [Related]
30. Intranasal Oxytocin Administration Dampens Amygdala Reactivity towards Emotional Faces in Male and Female PTSD Patients.
Koch SB; van Zuiden M; Nawijn L; Frijling JL; Veltman DJ; Olff M
Neuropsychopharmacology; 2016 May; 41(6):1495-504. PubMed ID: 26404844
[TBL] [Abstract][Full Text] [Related]
31. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder.
Guastella AJ; Howard AL; Dadds MR; Mitchell P; Carson DS
Psychoneuroendocrinology; 2009 Jul; 34(6):917-23. PubMed ID: 19246160
[TBL] [Abstract][Full Text] [Related]
32. Oxytocin-augmented social cognitive skills training in schizophrenia.
Davis MC; Green MF; Lee J; Horan WP; Senturk D; Clarke AD; Marder SR
Neuropsychopharmacology; 2014 Aug; 39(9):2070-7. PubMed ID: 24637803
[TBL] [Abstract][Full Text] [Related]
33. Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: a randomized pilot study.
Nave AM; Tolin DF; Stevens MC
J Clin Psychiatry; 2012 Sep; 73(9):1179-86. PubMed ID: 23059145
[TBL] [Abstract][Full Text] [Related]
34. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.
Guastella AJ; Dadds MR; Lovibond PF; Mitchell P; Richardson R
J Psychiatr Res; 2007 Sep; 41(6):466-71. PubMed ID: 16828803
[TBL] [Abstract][Full Text] [Related]
35. D-cycloserine-augmented one-session treatment of specific phobias in children and adolescents.
Farrell LJ; Waters AM; Oar EL; Tiralongo E; Garbharran V; Alston-Knox C; McConnell H; Collings N; Zimmer-Gembeck M; Donovan CL; Testa C; Storch EA; Ollendick TH
Brain Behav; 2018 Jun; 8(6):e00984. PubMed ID: 30106248
[TBL] [Abstract][Full Text] [Related]
36. Immersive 3D exposure-based treatment for spider fear: A randomized controlled trial.
Minns S; Levihn-Coon A; Carl E; Smits JAJ; Miller W; Howard D; Papini S; Quiroz S; Lee-Furman E; Telch M; Carlbring P; Xanthopoulos D; Powers MB
J Anxiety Disord; 2018 Aug; 58():1-7. PubMed ID: 29909286
[TBL] [Abstract][Full Text] [Related]
37. Neural responses during extinction learning predict exposure therapy outcome in phobia: results from a randomized-controlled trial.
Lange I; Goossens L; Michielse S; Bakker J; Vervliet B; Marcelis M; Wichers M; van Os J; van Amelsvoort T; Schruers K
Neuropsychopharmacology; 2020 Feb; 45(3):534-541. PubMed ID: 31352467
[TBL] [Abstract][Full Text] [Related]
38. Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment.
Quintana DS; Westlye LT; Rustan ØG; Tesli N; Poppy CL; Smevik H; Tesli M; Røine M; Mahmoud RA; Smerud KT; Djupesland PG; Andreassen OA
Transl Psychiatry; 2015 Jul; 5(7):e602. PubMed ID: 26171983
[TBL] [Abstract][Full Text] [Related]
39. Fear reactivation prior to exposure therapy: does it facilitate the effects of VR exposure in a randomized clinical sample?
Shiban Y; Brütting J; Pauli P; Mühlberger A
J Behav Ther Exp Psychiatry; 2015 Mar; 46():133-40. PubMed ID: 25460259
[TBL] [Abstract][Full Text] [Related]
40. Effects of post-session administration of methylene blue on fear extinction and contextual memory in adults with claustrophobia.
Telch MJ; Bruchey AK; Rosenfield D; Cobb AR; Smits J; Pahl S; Gonzalez-Lima F
Am J Psychiatry; 2014 Oct; 171(10):1091-8. PubMed ID: 25018057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
